CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a novel microfluidic chip-based system for point-of-care therapeutic drug monitoring in cancer treatment. By measuring plasma concentrations of anticancer drugs from small blood samples, it aims to personalize chemotherapy and improve patient outcomes.
Cancer claims almost 10 million lives annually, making it one of the major causes of death around the world.
Despite the development of novel drugs and treatment options, the 5-years survival of the most common cancers are still strikingly low.
Chemotherapy (CT) is a widely used option to treat malignancies, however CT protocols are established on a “one size fits all” basis and ignore inter-patient differences in drug pharmacokinetics which influence the blood levels of anticancer drugs, theref…
HUN-REN CENTRE FOR ENERGYRESEARCH
HUN-REN ENERGIATUDOMANYI KUTATOKOZPONT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
